Literature DB >> 25888649

The non-canonical role of vascular endothelial growth factor-C axis in cancer progression.

Chu-An Wang1, Shaw-Jenq Tsai2.   

Abstract

It has been shown in many clinical studies that the level of vascular endothelial growth factor-C (VEGF-C) positively correlates with lymph node metastasis. Nevertheless, beyond the canonical role of VEGF-C in stimulating lymphangiogenesis and thus promoting lymph node/distant metastasis, emerging evidence indicates that expression of VEGF-C contributes to various aspects of carcinogenicity via autocrine regulation. The newly identified functions of VEGF-C include but are not limited to proliferation, migration, invasion, and chemo-resistance. Besides tumor cell autocrine regulation, VEGF-C can also modulate the immune system such that tumor cells more easily escape immune surveillance. Therefore, understanding the functional roles and regulatory mechanisms related to the VEGF-C axis may lead to alternative strategies for cancer treatment. This mini-review will focus on summarizing recent discoveries regarding the unconventional functions of VEGF-C in cancer progression.
© 2015 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Vascular endothelial growth factor-C; autocrine; cancer stem cells; drug resistance; immunomodulation; lymphangiogenesis

Mesh:

Substances:

Year:  2015        PMID: 25888649      PMCID: PMC4935218          DOI: 10.1177/1535370215583802

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  83 in total

1.  Restoration of natural killer cell cytotoxicity by VEGFR-3 inhibition in myelogenous leukemia.

Authors:  Ji Yoon Lee; Sohye Park; Woo-Sung Min; Hee-Je Kim
Journal:  Cancer Lett       Date:  2014-08-23       Impact factor: 8.679

2.  Autophagy control by the VEGF-C/NRP-2 axis in cancer and its implication for treatment resistance.

Authors:  Marissa J Stanton; Samikshan Dutta; Heyu Zhang; Navatha S Polavaram; Alexey A Leontovich; Pia Hönscheid; Frank A Sinicrope; Donald J Tindall; Michael H Muders; Kaustubh Datta
Journal:  Cancer Res       Date:  2012-11-13       Impact factor: 12.701

3.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

4.  Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms.

Authors:  N Khromova; P Kopnin; V Rybko; B P Kopnin
Journal:  Oncogene       Date:  2011-08-01       Impact factor: 9.867

5.  Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis.

Authors:  Tatsuya Tanaka; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitsui; Takeyasu Katada; Midori Shiozaki; Yasuhiro Naganawa; Yoshitaka Fujii; Hiromitsu Takeyama
Journal:  J Exp Clin Cancer Res       Date:  2010-06-28

6.  A VEGFR-3 antagonist increases IFN-γ expression on low functioning NK cells in acute myeloid leukemia.

Authors:  Ji Yoon Lee; Sohye Park; Donghyun Curt Kim; Jae-Ho Yoon; Seung Hwan Shin; Woo-Sung Min; Hee-Je Kim
Journal:  J Clin Immunol       Date:  2013-02-13       Impact factor: 8.317

7.  Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma.

Authors:  Chih-Ming Su; Yen-Hao Su; Ching-Feng Chiu; Yi-Wen Chang; Chih-Chen Hong; Yang-Hao Yu; Yuan-Soon Ho; Chih-Hsiung Wu; Chia-Sheng Yen; Jen-Liang Su
Journal:  Ann Surg Oncol       Date:  2014-09-12       Impact factor: 5.344

8.  Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients.

Authors:  Ying-Chun Zhao; Xiao-Jian Ni; Ming-Hai Wang; Xiao-Ming Zha; Yi Zhao; Shui Wang
Journal:  Med Oncol       Date:  2012-05-06       Impact factor: 3.064

9.  VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development.

Authors:  E Kukk; A Lymboussaki; S Taira; A Kaipainen; M Jeltsch; V Joukov; K Alitalo
Journal:  Development       Date:  1996-12       Impact factor: 6.868

10.  Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.

Authors:  Ying-Chun Zhao; Xiao-Jian Ni; Yong Li; Min Dai; Zhong-Xu Yuan; Yong-Yun Zhu; Chuan-Yu Luo
Journal:  World J Surg Oncol       Date:  2012-08-20       Impact factor: 2.754

View more
  12 in total

1.  Expression of p-STAT3 and vascular endothelial growth factor in MNNG-induced precancerous lesions and gastric tumors in rats.

Authors:  Xiao-Yan Wang; Lou-Lei Wang; Xuan Zheng; Li-Na Meng; Bin Lyu; Hai-Feng Jin
Journal:  World J Gastrointest Oncol       Date:  2016-03-15

Review 2.  The Amide Local Anesthetic Lidocaine in Cancer Surgery-Potential Antimetastatic Effects and Preservation of Immune Cell Function? A Narrative Review.

Authors:  Thiên-Nga Chamaraux-Tran; Tobias Piegeler
Journal:  Front Med (Lausanne)       Date:  2017-12-20

3.  VEGF-C and Mortality in Patients With Suspected or Known Coronary Artery Disease.

Authors:  Hiromichi Wada; Masahiro Suzuki; Morihiro Matsuda; Yoichi Ajiro; Tsuyoshi Shinozaki; Satoru Sakagami; Kazuya Yonezawa; Masatoshi Shimizu; Junichi Funada; Takashi Takenaka; Yukiko Morita; Toshihiro Nakamura; Kazuteru Fujimoto; Hiromi Matsubara; Toru Kato; Takashi Unoki; Daisuke Takagi; Shuichi Ura; Kyohma Wada; Moritake Iguchi; Nobutoyo Masunaga; Mitsuru Ishii; Hajime Yamakage; Akira Shimatsu; Kazuhiko Kotani; Noriko Satoh-Asahara; Mitsuru Abe; Masaharu Akao; Koji Hasegawa
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

4.  DUSP2 regulates extracellular vesicle-VEGF-C secretion and pancreatic cancer early dissemination.

Authors:  Chu-An Wang; I-Heng Chang; Pei-Chi Hou; Yu-Jing Tai; Wan-Ning Li; Pei-Ling Hsu; Shang-Rung Wu; Wen-Tai Chiu; Chien-Feng Li; Yan-Shen Shan; Shaw-Jenq Tsai
Journal:  J Extracell Vesicles       Date:  2020-04-04

5.  Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration.

Authors:  Sela T Po'uha; Marion Le Grand; Miriam B Brandl; Andrew J Gifford; Gregory J Goodall; Yeesim Khew-Goodall; Maria Kavallaris
Journal:  Br J Cancer       Date:  2019-12-06       Impact factor: 7.640

6.  Knockdown of SLC39A4 Expression Inhibits the Proliferation and Motility of Gallbladder Cancer Cells and Tumor Formation in Nude Mice.

Authors:  Min Li; Kun Fan; Bohao Zheng; David Zekria; Tao Suo; Han Liu; Sheng Shen; Houbao Liu; Xiaoling Ni
Journal:  Cancer Manag Res       Date:  2021-03-08       Impact factor: 3.989

7.  Plump endothelial cells integrated into pre-existing venules contribute to the formation of 'mother' and 'daughter' vessels in pyogenic granuloma: possible role of galectin-1, -3 and -8.

Authors:  Enrique Arciniegas; Luz Marina Carrillo; Héctor Rojas; Jacinto Pineda; Richard Ramírez; Oscar Reyes; Marina Chopite; Albani Rocheta
Journal:  Scars Burn Heal       Date:  2021-01-22

Review 8.  Regulation of lymphangiogenesis by extracellular vesicles in cancer metastasis.

Authors:  Chu-An Wang; Shaw-Jenq Tsai
Journal:  Exp Biol Med (Maywood)       Date:  2021-06-18

9.  VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance.

Authors:  Signe R Michaelsen; Mikkel Staberg; Henriette Pedersen; Kamilla E Jensen; Wiktor Majewski; Helle Broholm; Mette K Nedergaard; Christopher Meulengracht; Thomas Urup; Mette Villingshøj; Slávka Lukacova; Jane Skjøth-Rasmussen; Jannick Brennum; Andreas Kjær; Ulrik Lassen; Marie-Thérése Stockhausen; Hans S Poulsen; Petra Hamerlik
Journal:  Neuro Oncol       Date:  2018-10-09       Impact factor: 12.300

10.  Clinical importance of VEGFC and PD-L1 co-expression in lung adenocarcinoma patients.

Authors:  Tingting Qin; Junling Xia; Shaochuan Liu; Jing Wang; Hailin Liu; Yan Zhang; Yanan Jia; Kai Li
Journal:  Thorac Cancer       Date:  2020-03-10       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.